Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
Foxconn's third quarter profit tumbles after iPhone X production hurdles
-
Fannie Mae Prices $1.161 Billion Connecticut Avenue Securities Risk Sharing Deal
-
Form 13F-NT NOMURA SECURITIES CO For: Sep 30
-
Form 13F-NT NOMURA GLOBAL FINANCIAL For: Sep 30
-
Form 13F-NT NOMURA SECURITIES INTERN For: Sep 30
-
Form 13F-NT NOMURA SECURITIES BERMUD For: Sep 30
-
Form 13F-NT NOMURA INTERNATIONAL For: Sep 30
-
Form 13F-HR NOMURA HOLDINGS INC For: Sep 30
-
Freddie Mac Prices New $3.5 Billion Three-Year Reference Notes Security
-
Form ABS-15G NOMURA ASSET ACCEPTANCE For: Sep 30
-
Venezuela says debt refinancing under way, S&P calls selective default
-
JD.com, Inc (JD) PT Raised to $52 at Nomura/Instinet Following 3Q Report
-
Form ABS-15G Nomura Home Equity Loan, For: Sep 30
-
LINE Corporation Announces Consolidated Financial Results for the Nine Months Ended September 30, 2017
-
Acushnet (GOLF) Prices 8.33M Share Common Offering at $17/Sh
-
China's economy cools as government curbs hit factories, property and retailers
-
Acushnet Holdings Corp. Announces Pricing of Offering of Common Stock by Selling Shareholder
-
Form 13F-HR NOMURA ASSET MANAGEMENT For: Sep 30
-
RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares
-
RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares
-
Freddie Mac Announces the Issuance of a New Three-Year Reference Notes Security
-
RedHill Biopharma Reports 2017 Third Quarter Financial Results
-
RedHill Biopharma Reports 2017 Third Quarter Financial Results
-
Form 6-K NOMURA HOLDINGS INC For: Nov 13
-
Acushnet (GOLF) Announces 8.3M Share Offering of Common Stock by Selling Shareholder
-
Acushnet Holdings Corp. Announces Offering of Common Stock by Selling Shareholder
-
Voyager Therapeutics Announces Closing of Public Offering of Common Stock
-
Nomura Maintains Bullish View on Himax (HIMX) Post Q3
-
Nvidia shares set record as Volta chips ensure future growth
-
UPDATE: Nomura/Instinet Upgrades NVIDIA (NVDA) to Neutral, 'Falling On Our Sword'
-
Under Armour, Inc. (UAA) PT Lowered to $9 at Nomura/Instinet Citing Concerns Over Future Re-Ratings
-
Taubman Appoints Two New Independent Directors and Announces Other Governance Enhancements
-
Tesla (TSLA) Will Sell As Many Cars As It Can Produce - Nomura/Instinet
-
LPL Investment (LPLA) PT Raised to $65 at Nomura/Instinet, Remains Top Pick
-
WISeKey announces the appointment of Wang Wei, Founding Chairman of China Mergers and Acquisitions Association (CMAA) to its Global Cybersecurity Blockchain Advisory Task Force
-
Ten Innovative Startups Featured at Accenture’s FinTech Innovation Lab Asia-Pacific Investor Day in Hong Kong’s Cyberport
-
Orchid Island Capital Announces November 2017 Monthly Dividend and October 31, 2017 RMBS Portfolio Characteristics
-
RedHill Biopharma (RDHL) Prices 4.1M ADS Offering at $5.50/Sh
-
RedHill Biopharma Prices Public Offering of its American Depositary Shares
-
RedHill Biopharma Prices Public Offering of its American Depositary Shares
-
TopBuild Corp (BLD) PT Raised to $61 at Nomura/Instinet on 3Q Report; 'Beat & Raise Margin'
-
Westlake Chemical (WLK) PT Raised to $108 at Nomura/Instinet on 3Q Report; 'Cyclical Tailwinds Prevailing in 2018'
-
Wall Street Veterans Join Singular Medical Technologies Board of Directors
-
Voyager Therapeutics (VYGR) Prices 4.5M Share Offering at $12/Sh
-
FMC Corp. (FMC) PT Raised to $106 at Nomura/Instinet
-
Extended Stay (STAY) PT Lowered to $23 at Nomura/Instinet
-
Voyager Therapeutics Announces Pricing of Public Offering of Common Stock
-
RedHill Biopharma (RDHL) Plans Offer of ADSs
-
RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares
-
RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares

